rs35818294

GWAS Catalog Trait Associations (10)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

metabolite measurement

Allele A
OR 0.35
p 8.0e-148
N 14,296
Large GWAS
European

glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement

Allele A
OR 0.33
p 7.0e-61
N 8,245
Large GWAS
European
Allele A
OR 0.32
p 3.0e-60
N 8,809
Large GWAS
European
Allele A
OR 0.13
p 2.0e-24
N 4,959
Large GWAS
European

glycosyl ceramide (d18:2/24:1, d18:1/24:2) measurement

Allele A
OR 0.31
p 2.0e-57
N 8,251
Large GWAS
European
Allele A
OR 0.37
p 1.0e-36
N 6,136
Large GWAS
European
Allele A
OR 0.14
p 2.0e-18
N 4,916
Large GWAS
European

glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement

Allele A
OR 0.30
p 1.0e-51
N 8,232
Large GWAS
European
Allele A
OR 0.35
p 2.0e-31
N 6,136
Large GWAS
European
Allele A
OR 0.14
p 3.0e-15
N 4,843
Large GWAS
European

glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement

Allele A
OR 0.30
p 2.0e-50
N 8,259
Large GWAS
European
Allele A
OR 0.12
p 1.0e-16
N 4,935
Large GWAS
European

serum metabolite level

Allele C
OR 0.36
p 8.0e-40
N 3,926
Large GWAS
Hispanic or Latin American

glycosyl-N-stearoyl-sphingosine (d18:1/18:0) measurement

Allele A
OR 0.24
p 9.0e-35
N 8,233
Large GWAS
European
Allele A
OR 0.21
p 3.0e-27
N 8,809
Large GWAS
European
Feofanova EV et al. Whole-Genome Sequencing Analysis of Human Metabolome in Multi-Ethnic Populations. Nature Communications 14(1):3111 (2023)
Allele A
OR 0.23
p 3.0e-22
N 5,646
Large GWAS
multi-ancestry
Allele A
OR 0.10
p 1.0e-11
N 4,941
Large GWAS
European

lipid measurement

Allele A
OR 0.45
p 4.0e-16
N 1,149
Large GWAS
European

level of ceramide

Allele A
OR 0.19
p 2.0e-14
N 5,309
Large GWAS
European
Allele A
OR 0.31
p 6.0e-28
N 4,492
Large GWAS
European

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…